Recent advances of the regulation roles of MicroRNA in glioblastoma

MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway

(2018) Shi Yin et al.   CANCER BIOLOGY & THERAPY

Gemcitabine and glioblastoma: challenges and current perspectives

(2018) Chiara Bastiancich et al.   DRUG DISCOVERY TODAY

Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2

(2018) Zhongjun Li et al.   ONCOLOGY RESEARCH

MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma

(2017) Zhen-Xiu Cheng et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Adult Glioblastoma

(2017) Brian M. Alexander et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor suppressive role of miR-194-5p in glioblastoma multiforme

(2017) Zhao Zhang et al.   Molecular Medicine Reports

Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells

(2017) Xiao Zhang et al.   NUCLEIC ACIDS RESEARCH

Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity

(2017) S. Sharif et al.   Stem Cell Reviews and Reports

MicroRNA–target cross-talks: Key players in glioblastoma multiforme

(2017) Eman Ali Toraih et al.   TUMOR BIOLOGY

MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase

(2017) Zhenyang Liu et al.   TUMOR BIOLOGY

Strategies of temozolomide in future glioblastoma treatment

(2017) Chooi Yeng Lee   OncoTargets and Therapy

MicroRNA-141 is a tumor regulator and prognostic biomarker in human glioblastoma

(2017) Xuehua Xiong et al.   Oncology Letters

A cerebrospinal fluid microRNA signature as biomarker for glioblastoma

(2017) Johnny C. Akers et al.   Oncotarget

Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity

(2017) S. Sharif et al.   Stem Cell Reviews and Reports

miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling

(2017) Shan-shan Wang et al.   Molecular Therapy-Nucleic Acids

A 4-miRNA signature to predict survival in glioblastomas

(2017) Simon K. Hermansen et al.   PLoS One

PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA

(2016) Zahid Nawaz et al.   Molecular Cancer

MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8

(2016) Hong Lee et al.   MOLECULES AND CELLS

MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme—a Systematic Overview

(2014) Michael Henriksen et al.   MOLECULAR NEUROBIOLOGY

New modalities of cancer treatment for NSCLC: focus on immunotherapy

(2014) Marianne Davies   Cancer Management and Research

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

(2013) Shuwei Qiu et al.   Journal of Translational Medicine

Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)

(2012) Alexandra R. Grassian et al.   JOURNAL OF BIOLOGICAL CHEMISTRY